Induction of Placental Heme Oxygenase-1 Is Protective Against TNFα-induced Cytotoxicity and Promotes Vessel Relaxation

[1]  P. Baker,et al.  Relationship of Cell Adhesion Molecule Expression to Endothelium-Dependent Relaxation in Normal Pregnancy and Pregnancies Complicated With Preeclampsia or Fetal Growth Restriction , 1999, The Journal of the Society for Gynecologic Investigation: JSGI.

[2]  L. Kobzik,et al.  Hypoxia induces severe right ventricular dilatation and infarction in heme oxygenase-1 null mice. , 1999, The Journal of clinical investigation.

[3]  A. Choi,et al.  Exogenous administration of heme oxygenase-1 by gene transfer provides protection against hyperoxia-induced lung injury. , 1999, The Journal of clinical investigation.

[4]  I. Sargent,et al.  Preeclampsia: an excessive maternal inflammatory response to pregnancy. , 1999, American journal of obstetrics and gynecology.

[5]  D. Faller.  ENDOTHELIAL CELL RESPONSES TO HYPOXIC STRESS , 1999, Clinical and experimental pharmacology & physiology.

[6]  L. Turka,et al.  Antibody-induced transplant arteriosclerosis is prevented by graft expression of anti-oxidant and anti-apoptotic genes , 1998, Nature Medicine.

[7]  K. Furuyama,et al.  Developmental changes of gene expression in heme metabolic enzymes in rat placenta , 1998, FEBS letters.

[8]  C. Schneeberger,et al.  Expression of endothelial (type III) nitric oxide synthase in cytotrophoblastic cell lines: regulation by hypoxia and inflammatory cytokines. , 1998, Placenta.

[9]  C. Graham,et al.  Heme oxygenase and nitric oxide synthase in the placenta of the guinea-pig during gestation. , 1998, Placenta.

[10]  Q. Chen,et al.  Cytotoxicity and apoptosis produced by arachidonic acid in HepG2 cells overexpressing human cytochrome P-4502E1. , 1998, Alcoholism, clinical and experimental research.

[11]  I. Johnson,et al.  Plasma from pre‐eclamptic women and functional change in myometrial resistance arteries , 1998, British journal of obstetrics and gynaecology.

[12]  A. Ahmed,et al.  Hemeoxygenase-1 inhibits human myometrial contractility via carbon monoxide and is upregulated by progesterone during pregnancy. , 1998, The Journal of clinical investigation.

[13]  Martin Whittle,et al.  Cellular localization of AT1 receptor mRNA and protein in normal placenta and its reduced expression in intrauterine growth restriction. Angiotensin II stimulates the release of vasorelaxants. , 1998, The Journal of clinical investigation.

[14]  H. Schröder,et al.  The nitric oxide donor SIN-1 protects endothelial cells from tumor necrosis factor-alpha-mediated cytotoxicity: possible role for cyclic GMP and heme oxygenase. , 1997, Journal of molecular and cellular cardiology.

[15]  N. Abraham,et al.  Heme Induces the Expression of Adhesion Molecules ICAM-1, VCAM-1, and E Selectin in Vascular Endothelial Cells , 1997, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[16]  Rui Wang,et al.  Carbon monoxide‐induced vasorelaxation and the underlying mechanisms , 1997, British journal of pharmacology.

[17]  A. Cederbaum,et al.  Cytotoxicity and Apoptosis Produced by Arachidonic Acid in Hep G2 Cells Overexpressing Human Cytochrome P4502E1* , 1997, The Journal of Biological Chemistry.

[18]  D. Kniss,et al.  Role of VEGF receptor-1 (Flt-1) in mediating calcium-dependent nitric oxide release and limiting DNA synthesis in human trophoblast cells. , 1997, Laboratory investigation; a journal of technical methods and pathology.

[19]  I. Greer,et al.  Inducible (type II) nitric oxide synthase in human placental villous tissue of normotensive, pre-eclamptic and intrauterine growth-restricted pregnancies. , 1997, Placenta.

[20]  S. Moncada.  Nitric Oxide in the Vasculature: Physiology and Pathophysiology , 1997, Annals of the New York Academy of Sciences.

[21]  W. Durante,et al.  Nitric oxide induces heme oxygenase-1 gene expression and carbon monoxide production in vascular smooth muscle cells. , 1997, Circulation research.

[22]  S. Ferry,et al.  Cardiovascular sequelae of toxaemia of pregnancy. , 1997, Heart.

[23]  S. Walsh,et al.  TNFα concentrations and mRNA expression are increased in preeclamptic placentas , 1996 .

[24]  N. Gorbunov,et al.  Nitric oxide/carbon monoxide. A molecular switch for myocardial preservation during ischemia. , 1996, Circulation.

[25]  R. A. Johnson,et al.  Heme oxygenase substrates acutely lower blood pressure in hypertensive rats. , 1996, The American journal of physiology.

[26]  U. Ekblad,et al.  Lipid peroxidation and antioxidants in normal and pre-eclamptic pregnancies. , 1996, Placenta.

[27]  T. Nakaki,et al.  Nitric oxide in vascular remodeling. , 1996, Japanese heart journal.

[28]  A. Jain,et al.  Role of bilirubin in pregnancy‐induced hypertension , 1996, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[29]  R. A. Rutherford,et al.  Nitric oxide synthase in human placenta and umbilical cord from normal, intrauterine growth‐retarded and pre‐eclamptic pregnancies , 1995, British journal of pharmacology.

[30]  A. Choi,et al.  Hemoglobin provides protection against lethal endotoxemia in rats: the role of heme oxygenase-1. , 1995, American journal of respiratory cell and molecular biology.

[31]  R. Arngrímsson,et al.  Death rates from ischemic heart disease in women with a history of hypertension in pregnancy , 1995 .

[32]  K. Vandegriff,et al.  Oxidative-stress response in vascular endothelial cells exposed to acellular hemoglobin solutions. , 1995, The American journal of physiology.

[33]  M. Gerritsen,et al.  Transfection of the human heme oxygenase gene into rabbit coronary microvessel endothelial cells: protective effect against heme and hemoglobin toxicity. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[34]  S. Kourembanas,et al.  Smooth muscle cell-derived carbon monoxide is a regulator of vascular cGMP. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[35]  S. Kostyk,et al.  Hypoxia inhibits expression of eNOS via transcriptional and posttranscriptional mechanisms. , 1994, The American journal of physiology.

[36]  K. Pavelić,et al.  Molecular Medicine , 1986, British Journal of Cancer.

[37]  J. Polak,et al.  Endothelial nitric oxide synthase in the human placenta: regional distribution and proposed regulatory role at the feto-maternal interface. , 1994, Placenta.

[38]  L. Myatt,et al.  Vasodilator Effects of Parathyroid Hormone, Parathyroid Hormone-Related Protein, and Calcitonin Gene-Related Peptide in the Human Fetal-Placental Circulation , 1994, The Journal of the Society for Gynecologic Investigation: JSGI.

[39]  James M. Roberts,et al.  Preeclampsia: More Than Pregnancy‐Induced Hypertension , 1994 .

[40]  J. Pollock,et al.  Immunohistochemical localization of nitric oxide synthase in the human placenta. , 1993, Placenta.

[41]  James M. Roberts,et al.  Pre-eclampsia: more than pregnancy-induced hypertension , 1993, The Lancet.

[42]  G. Vercellotti,et al.  Induction of heme oxygenase is a rapid, protective response in rhabdomyolysis in the rat. , 1992, The Journal of clinical investigation.

[43]  K. Laderoute,et al.  The identification of heme oxygenase as a major hypoxic stress protein in Chinese hamster ovary cells. , 1991, British Journal of Cancer.

[44]  L. Myatt,et al.  The action of nitric oxide in the perfused human fetal-placental circulation. , 1991, American journal of obstetrics and gynecology.

[45]  S. Brennecke,et al.  Role of endothelium-derived nitric oxide in maintenance of low fetal vascular resistance in placenta , 1990, The Lancet.

[46]  S. Pecorelli,et al.  Histological features of uteroplacental vessels in normal and hypertensive patients in relation to birthweight , 1989, British journal of obstetrics and gynaecology.

[47]  M. Maines.  Heme oxygenase: function, multiplicity, regulatory mechanisms, and clinical applications , 1988, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[48]  S. Shibahara,et al.  Human heme oxygenase cDNA and induction of its mRNA by hemin. , 1988, European journal of biochemistry.

[49]  B. Brüne,et al.  Inhibition of platelet aggregation by carbon monoxide is mediated by activation of guanylate cyclase. , 1987, Molecular pharmacology.

[50]  B. Ames,et al.  Antioxidant activity of albumin-bound bilirubin. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[51]  E. Beutler,et al.  Simplified determination of carboxyhemoglobin. , 1984, Clinical chemistry.

[52]  W. B. Robertson,et al.  FETAL GROWTH RETARDATION AND THE ARTERIES OF THE PLACENTAL BED , 1977, British journal of obstetrics and gynaecology.

[53]  F. Reilly,et al.  Neurohistochemical evidence supporting an absence of adrenergic and cholinergic innervation in the human placenta and umbilical cord , 1977, The Anatomical record.

[54]  Y. Niida,et al.  Oxidative stress causes enhanced endothelial cell injury in human heme oxygenase-1 deficiency. , 1999, The Journal of clinical investigation.

[55]  N. Abraham,et al.  Gene transfer of human heme oxygenase into coronary endothelial cells potentially promotes angiogenesis , 1998, Journal of cellular biochemistry.

[56]  D. Mann,et al.  Tumor Necrosis Factor- (cid:97) Confers Resistance to Hypoxic Injury in the Adult Mammalian Cardiac Myocyte , 2022 .

[57]  D. Willis,et al.  Heme oxygenase: A novel target for the modulation of inflammatory response , 1996, Nature Medicine.

[58]  S. Walsh,et al.  TNF alpha concentrations and mRNA expression are increased in preeclamptic placentas. , 1996, Journal of reproductive immunology.

[59]  G. Vercellotti,et al.  Endothelial cell heme oxygenase and ferritin induction by heme proteins: a possible mechanism limiting shock damage. , 1992, Transactions of the Association of American Physicians.

[60]  L. Myatt,et al.  Attenuation of the vasoconstrictor effects of thromboxane and endothelin by nitric oxide in the human fetal-placental circulation. , 1992, American journal of obstetrics and gynecology.